Elderly polypharmacy patients' needs and concerns regarding medication assessed using the structured patient-pharmacist consultation modelKovačević, S. V., Miljković, B., Vučićević, K., Ćulafić, M., Kovačević, M., Golubović, B., Jovanović, M. & de Gier, J. J., Sep-2017, In : Patient Education and Counseling. 100, 9, p. 1714-1719 6 p.
Research output: Contribution to journal › Article › Academic › peer-review
Objective: To evaluate elderly polypharmacy patients' needs and concerns regarding medication through the Structured Patient-Pharmacist Consultation (SPPC).
Methods: Older patients on chronic treatment with > 5 medications were asked to fill in the SPPC form at home. A consultation with the community pharmacist, structured according to patient's answers, followed within 2-4 weeks. Logistic regression associated patients' individual treatment with care issues and consultation outcomes.
Results: Out of 440 patients, 39.5% experienced problems, and 46.1% had concerns about medication use. 122 patients reported reasons for discontinuing treatment. The main outcome of the consultation was a better understanding of medication use (75.5%). Side effects and/or non-adherence were identified in 50% of patients, and 26.6% were referred to the doctor. Atrial fibrillation, COPD, anticoagulants, benzodiazepines, and beta agonists/corticosteroids were associated with problems during medication use. Patients with diabetes improved their understanding of medication use significantly.
Conclusion: Patients on benzodiazepines, anticoagulants, and beta agonists/corticosteroids, with atrial fibrillation and/or COPD, may have a higher potential for non-adherence. Counseling patients based on the SPPC model may be particularly useful for patients with diabetes. (C) 2017 Elsevier B.V. All rights reserved.
|Number of pages||6|
|Journal||Patient Education and Counseling|
|Publication status||Published - Sep-2017|
- Elderly patients, Poly-pharmacy, Adherence, Medication use, Community pharmacy, Structured patient-pharmacist consultation model, RANDOMIZED CONTROLLED-TRIAL, GENERAL-PRACTICE, RISK-FACTORS, MYOCARDIAL-INFARCTION, ATRIAL-FIBRILLATION, COMMUNITY PHARMACY, ADHERENCE, PERSISTENCE, BELIEFS, NONADHERENCE